Advanced Breast Cancer Therapy

TTC Oncology LLC is developing a novel, small-molecule therapy to address unmet needs of breast cancer patients with a drug therapy that interacts with estrogen receptor on tumor cells. Founded in July 2015, TTC Oncology has completed phase I trial at four clinical sites under the guidance of breast cancer oncologists and consultants with extensive experience in pharma and biotech.

International pivotal phase II studies are in preparation.

©2018 by TTC Oncology.